These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
274 related articles for article (PubMed ID: 33613117)
1. MEF2A-mediated lncRNA HCP5 Inhibits Gastric Cancer Progression via MiR-106b-5p/p21 Axis. Chen W; Zhang K; Yang Y; Guo Z; Wang X; Teng B; Zhao Q; Huang C; Qiu Z Int J Biol Sci; 2021; 17(2):623-634. PubMed ID: 33613117 [No Abstract] [Full Text] [Related]
2. Silencing of long non-coding RNA HCP5 inhibits proliferation, invasion, migration, and promotes apoptosis via regulation of miR-299-3p/SMAD5 axis in gastric cancer cells. Yin D; Lu X Bioengineered; 2021 Dec; 12(1):225-239. PubMed ID: 33371778 [TBL] [Abstract][Full Text] [Related]
3. LncRNA HCP5 Regulates Pancreatic Cancer Progression by miR-140-5p/CDK8 Axis. Yuan B; Guan Q; Yan T; Zhang X; Xu W; Li J Cancer Biother Radiopharm; 2020 Nov; 35(9):711-719. PubMed ID: 32407143 [No Abstract] [Full Text] [Related]
4. Long non-coding RNA HCP5 promotes proliferation and metastasis of clear cell renal cell carcinoma via targeting miR-140-5p/IGF1R pathway. Zhang YJ; Lu C Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):2965-2975. PubMed ID: 32271414 [TBL] [Abstract][Full Text] [Related]
5. Prader-Willi region non-protein coding RNA 1 suppressed gastric cancer growth as a competing endogenous RNA of Chen Z; Ju H; Yu S; Zhao T; Jing X; Li P; Jia J; Li N; Tan B; Li Y Clin Sci (Lond); 2018 May; 132(9):1003-1019. PubMed ID: 29535266 [TBL] [Abstract][Full Text] [Related]
6. The lncRNA MALAT1 participates in regulating coronary slow flow endothelial dysfunction through the miR-181b-5p-MEF2A-ET-1 axis. Zhao C; Zong Z; Zhu Q; Wang Y; Li X; Zhang C; Ma C; Xue Y Vascul Pharmacol; 2021 Jun; 138():106841. PubMed ID: 33545365 [TBL] [Abstract][Full Text] [Related]
8. MSC-induced lncRNA HCP5 drove fatty acid oxidation through miR-3619-5p/AMPK/PGC1α/CEBPB axis to promote stemness and chemo-resistance of gastric cancer. Wu H; Liu B; Chen Z; Li G; Zhang Z Cell Death Dis; 2020 Apr; 11(4):233. PubMed ID: 32300102 [TBL] [Abstract][Full Text] [Related]
9. The Effect of Long Non-Coding RNA (lncRNA) HCP5 on Regulating Epithelial-Mesenchymal Transition (EMT)-Related Markers in Gastric Carcinoma Is Partially Reversed by miR-27b-3p. Chen S; Ren C; Zheng H; Sun X; Dai J Med Sci Monit; 2020 May; 26():e921383. PubMed ID: 32357145 [TBL] [Abstract][Full Text] [Related]
10. Long Noncoding RNA Plasmacytoma Variant Translocation 1 Regulates Cisplatin Resistance via miR-3619-5p/TBL1XR1 Axis in Gastric Cancer. Wu C; Hu Y; Ning Y; Zhao A; Zhang G; Yan L Cancer Biother Radiopharm; 2020 Dec; 35(10):741-752. PubMed ID: 32407172 [No Abstract] [Full Text] [Related]
11. LncRNA FAM230B Promotes Gastric Cancer Growth and Metastasis by Regulating the miR-27a-5p/TOP2A Axis. Cui Y; Pu R; Ye J; Huang H; Liao D; Yang Y; Chen W; Yao Y; He Y Dig Dis Sci; 2021 Aug; 66(8):2637-2650. PubMed ID: 32910366 [TBL] [Abstract][Full Text] [Related]
12. LncRNA TP73-AS1 accelerates tumor progression in gastric cancer through regulating miR-194-5p/SDAD1 axis. Ding Z; Lan H; Xu R; Zhou X; Pan Y Pathol Res Pract; 2018 Dec; 214(12):1993-1999. PubMed ID: 30279010 [TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA HOTAIRM1 inhibits cell progression by regulating miR-17-5p/ PTEN axis in gastric cancer. Lu R; Zhao G; Yang Y; Jiang Z; Cai J; Zhang Z; Hu H J Cell Biochem; 2019 Apr; 120(4):4952-4965. PubMed ID: 30302796 [TBL] [Abstract][Full Text] [Related]
14. LncRNA HCP5 Induces Gastric Cancer Cell Proliferation, Invasion, and EMT Processes Through the miR-186-5p/WNT5A Axis Under Hypoxia. Gao M; Liu L; Yang Y; Li M; Ma Q; Chang Z Front Cell Dev Biol; 2021; 9():663654. PubMed ID: 34178988 [TBL] [Abstract][Full Text] [Related]
15. Downregulation of long noncoding RNA HCP5/miR-216a-5p/ZEB1 axis inhibits the malignant biological function of laryngeal squamous cell carcinoma cells. Zhang S; Huangfu H; Zhao Q; Li Y; Wu L Front Immunol; 2022; 13():1022677. PubMed ID: 36248798 [TBL] [Abstract][Full Text] [Related]
16. HCP5 contributes to cisplatin resistance in gastric cancer through miR-128/HMGA2 axis. Liang L; Kang H; Jia J Cell Cycle; 2021 Jun; 20(11):1080-1090. PubMed ID: 33993846 [TBL] [Abstract][Full Text] [Related]
17. LncRNA HCP5 promotes triple negative breast cancer progression as a ceRNA to regulate BIRC3 by sponging miR-219a-5p. Wang L; Luan T; Zhou S; Lin J; Yang Y; Liu W; Tong X; Jiang W Cancer Med; 2019 Aug; 8(9):4389-4403. PubMed ID: 31215169 [TBL] [Abstract][Full Text] [Related]
18. lncRNA MIR155HG Accelerates the Progression of Sepsis via Upregulating MEF2A by Sponging miR-194-5p. Zhang C; Li J; Li H; Wang G; Wang Q; Zhang X; Li B; Xu H DNA Cell Biol; 2021 Jun; 40(6):811-820. PubMed ID: 34030477 [TBL] [Abstract][Full Text] [Related]
19. MiR-17-5p promotes cellular proliferation and invasiveness by targeting RUNX3 in gastric cancer. Song J; Liu Y; Wang T; Li B; Zhang S Biomed Pharmacother; 2020 Aug; 128():110246. PubMed ID: 32447210 [TBL] [Abstract][Full Text] [Related]
20. LINC00240 promotes gastric cancer cell proliferation, migration and EMT via the miR-124-3p / DNMT3B axis. Li Y; Yan J; Wang Y; Wang C; Zhang C; Li G Cell Biochem Funct; 2020 Dec; 38(8):1079-1088. PubMed ID: 32526811 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]